Summit Therapeutics - ADR Peer Comparison
$13.62
As on 31-Aug-2026 16:14EDT
Market cap
$10,953 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
18.2
Div. Yield
0 %
$13.62
As on 31-Aug-2026 16:14EDT
Market cap
$10,953 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
18.2
Div. Yield
0 %